Non-Tuberculous Mycobacterial (NTM) Infections

Clinical trial pipeline · Data from ClinicalTrials.gov

See which Non-Tuberculous Mycobacterial (NTM) Infections trials you may qualify for

Total trials

Actively recruiting

Phase 3 trials

Completed

Trial phase breakdown

Trial status

Actively recruiting — 2 trials

RecruitingNot Applicable

NCT07131774

Treatment Monitoring for NTM Infections With a Symptom Diary

The primary aim of the study is to investigate the correlation between patient-reported symptoms recorded in the diary and the microbiological and radiological…

Germany200 participantsStarted 2025-07-11

Treatment: Filling in a symptom diary

RecruitingNot Applicable

NCT06522347

Mycobacteria Registry Study: Prospective Observational Study in Austria

The goal of this non-interventional registry study is to systematically collect epidemiological and clinical data throughout the treatment course to learn about…

Austria1,000 participantsStarted 2023-01-01

All recent trials (18 shown)

Not Yet RecruitingPhase 2

NCT07485010

Testing a Novel Combination Treatment (Arm D) Versus Standard of Care for Intensive Phase Treatment for Mycobacterium Ab…

The goal of this clinical trial is to learn if a new combination antibiotic treatment (Arm D) works to treat a rare lung condition called mycobacterium abscessu…

Location not specified300 participantsStarted 2027-04

Treatment: Sulbactam 25mg/kg -Durlobactam 25mg/kg (Every 6 hours), Ceftriaxone for Injection

AVAILABLENot Applicable

NCT04334070

Lamprene Multiple Patient Program

Lamprene®/Clofazimine, is a product of the pharmaceutical company named Novartis Pharmaceuticals Corporation. Lamprene®/Clofazimine is approved by FDA (the U.S…

Location not specified

Treatment: Lamprene®/Clofazimine

Non-Tuberculous Mycobacterial (NTM) Infections

Trial phase breakdown

Trial status

Actively recruiting — 2 trials

Treatment Monitoring for NTM Infections With a Symptom Diary

Mycobacteria Registry Study: Prospective Observational Study in Austria

All recent trials (18 shown)

Testing a Novel Combination Treatment (Arm D) Versus Standard of Care for Intensive Phase Treatment for Mycobacterium Ab…

Lamprene Multiple Patient Program

Trial phase breakdown

Trial status

Actively recruiting — 2 trials

Treatment Monitoring for NTM Infections With a Symptom Diary

Mycobacteria Registry Study: Prospective Observational Study in Austria

All recent trials (18 shown)

Testing a Novel Combination Treatment (Arm D) Versus Standard of Care for Intensive Phase Treatment for Mycobacterium Ab…

Lamprene Multiple Patient Program

Bacteriophage Therapy for Mycobacterium Abscessus Pulmonary Infection

ICoN-1 Phase 3 Study of the Efficacy and Safety of Treatment With MNKD-101, Clofazimine Inhalation Suspension

Mycobacteriophage Treatment of Non-tuberculosis Mycobacteria

Study of Epetraborole in Patients With Treatment-refractory MAC Lung Disease

A Study on Rare Dermatological Infections Conducted at Three Major Reference Hospitals in Costa Rica.

Pilot Trial of Inhaled Molgramostim in Non-tuberculous Mycobacterial (NTM) Infection

A Pilot Study to Assess the Effect of Intermittent iNO on the Treatment of NTM Lung Infection in CF and Non-CF Patients

Performance Evaluation of the VIDAS TB-IGRA Assay.

A Proof of Concept Study of Inhaled Nitric Oxide for Adults With Pulmonary Non-Tuberculous Mycobacterial Infection

Prolonged-Use of Inhaled Gaseous Nitric Oxide (gNO) for Adult With Non-Tuberculous Mycobacteria Infection

Prevalence and Characteristics of Patients With Bronchiectasis Comorbid Nontuberculous Mycobacteria

Microbiome in Pulmonary Tuberculosis, Non-tuberculous Mycobacterial Pulmonary Diseases, Lung Cancer and Hemoptysis

A Prospective Registry For Patients With Non-Tuberculous Mycobacterial (NTM) Pulmonary Disease in Korea.

A Prospective Registry For Non Tuberculous Mycobacterial (NTM) Infections